Private Advisor Group’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-6,941
| Closed | -$54.9K | – | 2439 |
|
2024
Q2 | $54.9K | Hold |
6,941
| – | – | ﹤0.01% | 2266 |
|
2024
Q1 | $94K | Buy |
6,941
+194
| +3% | +$2.63K | ﹤0.01% | 2204 |
|
2023
Q4 | $72.9K | Buy |
6,747
+1,600
| +31% | +$17.3K | ﹤0.01% | 2143 |
|
2023
Q3 | $33.5K | Buy |
5,147
+841
| +20% | +$5.47K | ﹤0.01% | 1996 |
|
2023
Q2 | $77K | Buy |
4,306
+400
| +10% | +$7.15K | ﹤0.01% | 1945 |
|
2023
Q1 | $91.8K | Buy |
3,906
+100
| +3% | +$2.35K | ﹤0.01% | 1872 |
|
2022
Q4 | $25K | Buy |
3,806
+396
| +12% | +$2.6K | ﹤0.01% | 952 |
|
2022
Q3 | $109K | Sell |
3,410
-1,200
| -26% | -$38.4K | ﹤0.01% | 1767 |
|
2022
Q2 | $181K | Sell |
4,610
-180
| -4% | -$7.07K | ﹤0.01% | 1863 |
|
2022
Q1 | $192K | Buy |
4,790
+1,791
| +60% | +$71.8K | ﹤0.01% | 1907 |
|
2021
Q4 | $151K | Sell |
2,999
-1,420
| -32% | -$71.5K | ﹤0.01% | 1972 |
|
2021
Q3 | $288K | Buy |
4,419
+2,046
| +86% | +$133K | ﹤0.01% | 1716 |
|
2021
Q2 | $92K | Sell |
2,373
-352
| -13% | -$13.6K | ﹤0.01% | 1906 |
|
2021
Q1 | $143K | Buy |
2,725
+427
| +19% | +$22.4K | ﹤0.01% | 1778 |
|
2020
Q4 | $156K | Sell |
2,298
-449
| -16% | -$30.5K | ﹤0.01% | 1659 |
|
2020
Q3 | $106K | Hold |
2,747
| – | – | ﹤0.01% | 1486 |
|
2020
Q2 | $107K | Buy |
2,747
+615
| +29% | +$24K | ﹤0.01% | 1667 |
|
2020
Q1 | $64K | Buy |
2,132
+765
| +56% | +$23K | ﹤0.01% | 1355 |
|
2019
Q4 | $154K | Sell |
1,367
-134
| -9% | -$15.1K | ﹤0.01% | 1527 |
|
2019
Q3 | $50K | Buy |
1,501
+300
| +25% | +$9.99K | ﹤0.01% | 1591 |
|
2019
Q2 | $51K | Buy |
1,201
+194
| +19% | +$8.24K | ﹤0.01% | 1624 |
|
2019
Q1 | $55K | Buy |
1,007
+10
| +1% | +$546 | ﹤0.01% | 1513 |
|
2018
Q4 | $30K | Buy |
997
+500
| +101% | +$15K | ﹤0.01% | 1338 |
|
2018
Q3 | $23K | Buy |
+497
| New | +$23K | ﹤0.01% | 1578 |
|
2018
Q2 | – | Sell |
-350
| Closed | -$13K | – | 1392 |
|
2018
Q1 | $13K | Buy |
+350
| New | +$13K | ﹤0.01% | 1143 |
|